Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gaurav Syal

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Gastroenterology|December 21, 2023
AGA Clinical Practice Guideline on the Management of Pouchitis and Inflammatory Pouch DisordersEdward L Barnes, Manasi Agrawal, Gaurav Syal, et al.
Diseases of the Colon and Rectum|September 13, 2021
Preoperative Serum Vedolizumab Levels Do Not Impact Postoperative Outcomes in Inflammatory Bowel DiseaseAaron B Parrish, Nicole E Lopez, Adam Truong, et al.
Digestive Diseases and Sciences|November 28, 2023
Comparative Persistence of Non-tumor Necrosis Factor (TNF) vs. TNF Antagonists for Post-operative Prophylaxis in Crohn's Disease (CD)Phillip Gu, Shishir Dube, YooJin Lee, et al.
Inflammatory Bowel Diseases|July 19, 2021
Health Maintenance Consensus for Adults With Inflammatory Bowel DiseaseGaurav Syal, Mariastella Serrano, Animesh Jain, et al.
Inflammatory Bowel Diseases|February 28, 2019
Efficacy of Vedolizumab for Refractory Pouchitis of the Ileo-anal Pouch: Results From a Multicenter US CohortMartin Gregory, Kimberly N Weaver, Patrick Hoversten, et al.
Digestive Diseases and Sciences|January 10, 2022
Appropriateness of Medical and Surgical Treatments for Chronic Pouchitis Using RAND/UCLA Appropriateness MethodologyGaurav Syal, Miles P Sparrow, Fernando Velayos, et al.
Inflammatory Bowel Diseases|March 26, 2024
Real-World Effectiveness of Ustekinumab in Ulcerative Colitis in a United States Multicenter Cohort ConsortiumAndres J Yarur, Ryan Ungaro, Katherine Huang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 7, 2022
Comparative Safety and Effectiveness of Biologic Therapy for Crohn's Disease: A CA-IBD Cohort StudySiddharth Singh, Jihoon Kim, Jiyu Luo, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 17, 2020
Real-World Effectiveness and Safety of Tofacitinib in Crohn's Disease and IBD-U: A Multicenter Study From the TROPIC ConsortiumMarc Fenster, Quazim A Alayo, Aava Khatiwada, et al.
World Journal of Gastrointestinal Surgery|April 5, 2024
Pre-operative visceral adipose tissue radiodensity is a potentially novel prognostic biomarker for early endoscopic post-operative recurrence in Crohn's diseasePhillip Gu, Shishir Dube, Norman Gellada, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Gastroenterology|December 21, 2023
AGA Clinical Practice Guideline on the Management of Pouchitis and Inflammatory Pouch DisordersEdward L Barnes, Manasi Agrawal, Gaurav Syal, et al.
Diseases of the Colon and Rectum|September 13, 2021
Preoperative Serum Vedolizumab Levels Do Not Impact Postoperative Outcomes in Inflammatory Bowel DiseaseAaron B Parrish, Nicole E Lopez, Adam Truong, et al.
Digestive Diseases and Sciences|November 28, 2023
Comparative Persistence of Non-tumor Necrosis Factor (TNF) vs. TNF Antagonists for Post-operative Prophylaxis in Crohn's Disease (CD)Phillip Gu, Shishir Dube, YooJin Lee, et al.
Inflammatory Bowel Diseases|July 19, 2021
Health Maintenance Consensus for Adults With Inflammatory Bowel DiseaseGaurav Syal, Mariastella Serrano, Animesh Jain, et al.
Inflammatory Bowel Diseases|February 28, 2019
Efficacy of Vedolizumab for Refractory Pouchitis of the Ileo-anal Pouch: Results From a Multicenter US CohortMartin Gregory, Kimberly N Weaver, Patrick Hoversten, et al.
Digestive Diseases and Sciences|January 10, 2022
Appropriateness of Medical and Surgical Treatments for Chronic Pouchitis Using RAND/UCLA Appropriateness MethodologyGaurav Syal, Miles P Sparrow, Fernando Velayos, et al.
Inflammatory Bowel Diseases|March 26, 2024
Real-World Effectiveness of Ustekinumab in Ulcerative Colitis in a United States Multicenter Cohort ConsortiumAndres J Yarur, Ryan Ungaro, Katherine Huang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 7, 2022
Comparative Safety and Effectiveness of Biologic Therapy for Crohn's Disease: A CA-IBD Cohort StudySiddharth Singh, Jihoon Kim, Jiyu Luo, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 17, 2020
Real-World Effectiveness and Safety of Tofacitinib in Crohn's Disease and IBD-U: A Multicenter Study From the TROPIC ConsortiumMarc Fenster, Quazim A Alayo, Aava Khatiwada, et al.
World Journal of Gastrointestinal Surgery|April 5, 2024
Pre-operative visceral adipose tissue radiodensity is a potentially novel prognostic biomarker for early endoscopic post-operative recurrence in Crohn's diseasePhillip Gu, Shishir Dube, Norman Gellada, et al.
Pageof 6